MAPK8 and Hepatic steatosis: Mechanistically, CES2 promotes lipid oxidation to reverse hepatic steatosis and dissociates activation of ER stress, as well as the downstream effector proteins IKK and JNK, from inflammation, Akt activation, and glucose intolerance.